Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

VTGN Stock Annual Cash Flow. Download in Excel

VistaGen Therapeutics Inc. logo

VistaGen Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

2.50
 
USD
  
0.25
  
(11.11%)
Previous close: 2.25  Open: 2.25  Bid: 2.5  Ask: 2.6
52 week range    
2.22   
   5.86
Mkt Cap: 68 M  Avg Vol (90 Days): 295,224
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 23rd December 2024

Stock Rankings

49
MarketXLS Rank
60
Value
46
Technical
42
Quality
How are these ranks calculated?
Search for a stock

Financials

VTGN Cash Flow

Annual
Mar-15Mar-16Mar-17Mar-18Mar-19Mar-20Mar-21Mar-22Mar-23Mar-24
(Increase) Decrease in other current assets146300.090500.0
(Increase) Decrease in other current liabilities4 M-2 M206000.0516000.0
(Increase) Decrease in payables2 M-547200.0-451700.0541700.01 M-390700.051000.02 M-934000.0522000.0
(Increase) Decrease in receivables134900.0-300000.0300000.0-40600.0
Amortization of intangibles510800.0105900.0
CapitalExpenditureReported26300.0239100.01600.0174000.0275400.0200400.0528000.0
Cash at beginning of period70000.0428500.03 M10 M13 M1 M103 M68 M17 M
Cash at end of period70000.0428500.03 M10 M13 M1 M1 M68 M17 M119 M
Cash flow-12 M-5 M-7 M-9 M-15 M-16 M-12 M-46 M-50 M-26 M
CashFlowFromContinuingInvestingActivities-26300.0-239100.0-1600.0-174000.0-275400.0-200400.0-740000.0-61000.0
ChangeInAccountPayable2 M-547200.0-451700.0541700.01 M-390700.051000.02 M-934000.0522000.0
ChangeInPayablesAndAccruedExpense2 M-547200.0-451700.0541700.01 M-390700.051000.02 M-934000.0522000.0
ChangeInPrepaidAssets107400.025700.0-227700.0131200.0589000.0182600.0-328400.0-2 M3 M250000.0
ChangeInWorkingCapital2 M-521500.0-679400.0819200.02 M91900.03 M-2 M2 M1 M
Depreciation59100.053500.054900.080700.091200.0103100.0117600.0153500.0130000.0127000.0
Depreciation unreconciled59100.0590800.0138600.080700.0602000.0544400.0477600.0711100.0532000.0568000.0
DepreciationAndAmortization59100.0590800.0138600.080700.0602000.0544400.0477600.0711100.0532000.0568000.0
FinancingCashFlow3 M5 M10 M17 M17 M4 M114 M10 M-1 M128 M
Free cash flow-3 M-5 M-8 M-9 M-15 M-16 M-12 M-45 M-50 M-26 M
GainLossOnSaleOfPPE2300.06000.0
IncomeTaxPaidSupplementalData2400.02400.02400.02600.02600.02600.03400.0
InterestPaidSupplementalData12700.016600.08900.08000.014800.013300.0300.0
Issuance of capital stock280000.010 M17 M17 M4 M16 M93 M
Issuance of debt-111500.0-182200.0-203000.0-220500.0-293600.0-378700.0-1 M-985000.0
IssuanceOfCapitalStock280000.010 M17 M17 M4 M16 M93 M
IssuanceOfDebt-112500.0-183500.0-205400.0-223200.0-296600.0-382000.0-3000.0-1 M-985000.0
Net cash from financing activities5 M10 M17 M17 M4 M113 M6 M-1 M128 M
Net cash from investing activities-26300.0-239100.0-1600.0-174000.0-275400.0-200400.0-740000.0-61000.0
Net cash from operating activities-3 M-5 M-7 M-9 M-15 M-16 M-12 M-45 M-50 M-26 M
Net change in cash & cash equivalents70000.0358500.02 M7 M3 M-12 M102 M-35 M-51 M103 M
Net income from continuing operations-14 M-47 M-10 M-14 M-25 M-21 M-18 M-48 M-59 M-29 M
NetCommonStockIssuance280000.010 M17 M17 M4 M16 M93 M
NetForeignCurrencyExchangeGainLoss-6400.0
NetInvestmentPropertiesPurchaseAndSale-200400.0-212000.0-61000.0
NetInvestmentPurchaseAndSale-200400.0-212000.0-61000.0
NetIssuancePaymentsOfDebt-112500.0-183500.0-205400.0-223200.0-296600.0-382000.0-3000.0-1 M-985000.0
NetLongTermDebtIssuance-1000.0-1300.0-2400.0-2700.0-3000.0-3300.0-3000.0-1500.0
NetPPEPurchaseAndSale-26300.0-239100.0-1600.0-174000.0-275400.0-200400.0-528000.0
NetPreferredStockIssuance5 M278000.094 M
Operating (gains) losses27 M135000.022700.06000.0
Other financing charges net6 M6 M
Other investing changes net-200400.0-212000.0-61000.0
Other non-cash items3 M16 M4 M4 M8 M4 M2 M3 M7 M2 M
PreferredStockIssuance5 M278000.094 M
ProceedsFromIssuanceOfWarrants605700.0710000.013 M239400.0
ProceedsFromStockOptionExercised139900.0104000.0
Purchase of property plant & equipment-26300.0-239100.0-1600.0-174000.0-275400.0-200400.0-528000.0
PurchaseOfPPE-26300.0-239100.0-1600.0-174000.0-275400.0-200400.0-528000.0
Repayment of debt-1000.0-1300.0-2400.0-2700.0-3000.0-3300.0-3000.0-1500.0
RepaymentOfDebt-112500.0-183500.0-205400.0-223200.0-296600.0-606400.0-3000.0-1 M-985000.0
Revenue per share537300.083700.0146300.0510800.0441300.0360000.0557600.0402000.0441000.0
ShortTermDebtIssuance224400.0
ShortTermDebtPayments-111500.0-182200.0-203000.0-220500.0-293600.0-603100.0-1 M-985000.0
StockBasedCompensation4 M851300.02 M3 M4 M2 M3 M3 M2 M
UnrealizedGainLossOnInvestmentSecurities78000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University